PHARMA

  • Hyderabad tycoon kidnap bid case solved, police arrest ex-CRPF constable November 21, 2014

    Hyderabad: The Hyderabad Police has solved the Banjara Hills firing case within 24 hours and declared a 37-year-old former CRPF constable Puli Obulesh as the main accused in the case. The police have seized an AK-47 with magazines, seven live rounds, 10 empty cartridges, rope, knife and a wig that...
  • Hyderabad: Police constable arrested in connection with attack on Aurobindo Pharma Director November 20, 2014

    Hyderabad: A Telangana Police constable has been arrested in connection with the failed abduction bid attack on Aurobindo Pharma Director K Nityananda Reddy. The police nabbed the accused by tracking a mobile signal. He was held while he was trying to flee on a bus to Bengaluru. Police is probing...
  • Attack on business tycoon with AK-47 shocks Hyderabad November 19, 2014

    Hyderabad: On Wednesday morning, an unidentified person with an AK 47 opened fired at a top industrialist in the posh and busy locality of Banjara Hills. K Nityananda Reddy, vice chairman of Aurobindo Pharma, one of the top pharmaceutical companies in India, fortunately escaped unhurt. The police are investigating the...
  • Hyderabad: Unidentified assailants shoot at Aurobindo Pharma Director KN Reddy November 19, 2014

    Hyderabad: It was a narrow escape for Aurobindo Pharma's Director K Nityananda Reddy on Wednesday morning when a man wielding an AK-47 rifle allegedly tried to abduct the businessman in Banjara Hills in Hyderabad. When he resisted, the unidentified gunman fired three rounds in the air before fleeing the scene....
  • MCI probes nexus between doctors, pharma companies: Reactions from across the nation November 18, 2014

    The Medical Council of India has ordered a probe after allegations surfaced that a Gujarat based firm had bribed doctors. CNN-IBN takes views of people from across the country. ...
  • Indian diabetics consume high amount of carbohydrates: Study November 18, 2014

    Mumbai: The Indian diabetics' population, which is second largest in the world with an estimated 65 million affected people, consumes high amount of carbohydrates, according to a study. The dietary habits of diabetics are not much different from those of non-diabetics, as per the recent STARCH study conducted by Bayer...
  • Bilaspur sterilisation deaths: Raids being conducted by government in all medical shops in Chhattisgarh November 14, 2014

    Bilaspur: Raids were conducted on Friday by health department officials in all the medical shops in Chhattisgarh. The raid took place in Raigarh, Dhamtari, Korba, Janjgir-Champa, Sukma and other districts. Reportedly, collectors are to inspect all the private hospitals in the districts and see that the banned drugs are not...
  • Sensex ends 68 points down; HPCL, BPCL slip 4-6 per cent on excise hike November 13, 2014

    Mumbai: The market has ended lower. The Sensex was down 68.26 points or at 27940.64 and the Nifty slipped 25.45 points at 8357.85. About 1334 shares advanced, 1716 shares declined and 105 shares were unchanged. Tata Power, Sesa Sterlite, ONGC, GAIL and Hero Moto were major laggards. On the gaining...
  • Modi asked to resist US pressure on IP and pharma sector September 26, 2014

    New York: An international medical agency on Friday asked Prime Minister Narendra Modi to resist US pressure to drop the use of public health safeguards in its intellectual property laws, which it said has enabled India to become the 'pharmacy of the developing world'. "India's production of affordable medicines is a...
  • US drug patent expiries to benefit Indian pharma industry September 10, 2014

    Mumbai: Expiry of drug patents in the US is great news for not only consumers but also the domestic pharmaceutical industry, where generics account for about 75 per cent of total sales, CARE Ratings said in its report released on Wednesday. Indian pharmaceutical companies have an opportunity to capitalise on the...
  • In race for bigger margins, drug makers willing to lose the India 'advantage' August 29, 2014

    Mumbai: Indian drug makers are fleeing a regulatory morass at home and moving some research and development to Europe and the United States as they try to boost margins by producing highvalue drugs. India's $15 billion a year pharma industry, the world's largest source of cheap generics, is already reeling from...
  • Andhra HC lifts stay on merger between Ranbaxy, Sun Pharma May 24, 2014

    The Andhra Pradesh High Court on Saturday vacated a status quo order it had issued earlier on Sun PharmaRanbaxy merger process, paving the way for the pharma giants becoming a single entity. While vacating the status quo, Justice G Chandraiah also disposed of the petition filed by two investors requesting the...
  • Andhra Pradesh HC verdict on Sun PharmaRanbaxy merger plea on Saturday May 23, 2014

    Hyderabad: The Andhra Pradesh High Court will on Saturday decide on the petition filed by two investors requesting it to restrain the BSE and NSE from giving any clearance to the scheme of amalgamation or merger between Sun Pharma and Ranbaxy. After hearing the arguments from the counsels of the petitioners,...
  • SC asks Andhra HC to decide on RanbaxySun Pharma merger May 21, 2014

    New Delhi: The Supreme Court on Wednesday asked the Andhra Pradesh High Court, which had passed an interim order staying the $4 billion merger of Ranbaxy with Sun Pharma, to decide the issue within two days. Hearing appeals filed by Sun Pharmaceutical, Ranbaxy Laboratories and Daiichi Sankyo Company against HC interim...
  • Cabinet clears KKR investments in two pharma companies May 13, 2014

    The government on cleared private equity major KKR's proposal to acquire stakes in two pharmaceutical companies in deals worth over Rs 1,400 crore, including 38 per cent stake buy in Gland Pharma. The two deals are estimated to be worth Rs 1,434 crore, sources said. In the first proposal, the Cabinet...
  • Make essential drugs affordable for all: Cipla May 4, 2014

    New Delhi: Amid US firms' allegations of patent norm violations against Indian pharma companies, leading domestic drug maker Cipla has said that "essential" medicines be made available to people at affordable rates and should not be sold under "monopoly". "As a scientist I believe that an inventor or innovator of a...
  • News 360: Huge turnout on first poll phase in Assam, Tripura April 7, 2014

    An estimated 72 per cent of the 64.4 lakh voters exercised their franchise peacefully in five Lok Sabha constituencies in Assam sealing the electoral fate of 51 contestants, including two union ministers in the first phase. ...
  • Sun Pharma to buy Ranbaxy in $3.2 billion deal April 7, 2014

    Tokyo: Sun Pharmaceutical Industries Ltd said it will buy generic drug maker Ranbaxy Laboratories Ltd, which has hit regulatory snags in its key US market over quality issues, in an all-share deal with total equity value of $3.2 billion. Ranbaxy, India's No.1 drugmaker by sales and 63.4 per cent held by...
  • Sensex ends 67 points up to end at record close March 5, 2014

    Mumbai: The benchmark Sensex on Wednesday extended gains by rising 67 points to end near its record close on sustained buying driven by positive global cues. Thawing of Ukraine crisis and upbeat economic data from China helped domestic markets, said traders. After gaining 263.08 points in the previous session, the Sensex...
  • IT, pharma sectors likely to be backbone of Telangana February 21, 2014

    Post bifurcation of Andhra Pradesh, the information technology and pharmaceuticals manufacturing sectors may become backbone of Telangana economy, leaving power production, ports and oil and natural gas to play a pivotal role in driving prosperity in the residuary state. With nearly 1,000 kmlong coast line, the coastal Andhra has major private...
  • Sensex rises 66 points to end at 20,376.56 February 7, 2014

    Mumbai: The Sensex on Friday rose for the fourth straight day and ended 66 points up at oneweek high levels led by gains in Tata Steel, Sun Pharma and Sesa Sterlite, amid volatility ahead of advance growth estimates for 2013/14. The index, which had gained 101 points in the previous three...
  • 19-year-old B Pharma student 'ragged' by seniors, attempts suicide September 4, 2013

    A 19-year-old B. Pharma student jumped from the third floor of her college building in Lucknow due to alleged harassment by fellow students and ragging, police said on Wednesday. Sambul Ishaq, a B Pharma student at M C Saxena Institute of Engineering and Management, was severely injured after she jumped from...
  • SC to hear PIL on the pricing of drugs in India August 5, 2013

    New Delhi: The Supreme Court on Monday will hear a PIL by the pharma companies on the pricing of medicines in India. The PIL was filed by four pharma firms who challenged the Delhi High Court's order to reduce the prices of certain medicines. These pharma companies were also asked to...
  • Italian Trentin wins Tour de France stage 14 July 13, 2013

    Lyon: Italian Matteo Trentin won the 14th stage of the Tour de France, a 191km undulating ride from Saint Pourcain sur Sioule on Saturday. The Omega PharmaQuick Step rider beat breakaway companions Michael Albasini of Switzerland and American Andrew Talansky who finished second and third. ....
  • Ranbaxy case: Should Indian patients worry over substandard drugs? June 5, 2013

    Mumbai: India exports drugs worth more than 15 billion dollars every year, a majority of which are USbound. Questions are being raised about the standards and quality, after Ranbaxy's whopping 500 million dollar settlement with the US government. The generic drugs in question were manufactured at Ranbaxy's plants in Paonta...
  • PIL in SC against Ranbaxy for manufacturing adulterated drugs June 5, 2013

    New Delhi: A Publicinterest litigation (PIL) has been moved in the Supreme Court against Ranbaxy Pharma. The PIL is seeking prosecution of all Ranbaxy directors and sealing of its manufacturing units at Paonta Sahib and Devas. This was based on Ranbaxy USA's 500 million dollar settlement with the US for...
  • Patent row: Delhi HC to hear diabetes drug case May 23, 2013

    New Delhi: The patent battle between US pharmaceuticals major Merck Sharp and Dohme (MSD) and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday. Indian pharma company Glenmark recently came out with generic versions of Merck's type2...
  • Ranbaxy fined $ 500 mn for selling adulterated drugs May 14, 2013

    New Delhi: Generic drugmaker Ranbaxy has been fined $500 million by the US government after its subsidiary pleaded guilty to sale of adulterated drugs manufactured in India. It is the largest settlement by a generic medicine maker till date. It includes $150 million in payments for a criminal fine and...
  • Jagan's DA case: CBI may file supplementary chargesheet April 2, 2013

    Hyderabad: The CBI, probing the alleged disproportionate assets case involving YSR Congress chief YS Jaganmohan Reddy, on Monday said it could file a supplementary chargesheet in the case on Tuesday. The central agency made this submission before a special CBI court here while seeking extension of judicial remand of Jagan...
  • Investments in India by global pharma cos to continue: Vikas Dandekar April 1, 2013

    In a landmark verdict, the Supreme Court dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glivec, paving the way for more affordable lifesaving cancer drugs. How does it affect the Indian pharmaceutical industry and the global biggies who are looking...